How to pay the least
Ask for the cash price
Tabloid
We didn’t find one.
- Ask your pharmacy for Tabloid’s cash price, and one or two other pharmacies too.
Compare every option
Details for each option
Brand nameNo maker’s card
We didn’t find a savings card or cash price from Tabloid’s maker. Ask the pharmacy for Tabloid’s cash price. With insurance, ask what your plan charges.
Authorized genericNot sold
There isn’t one. An authorized generic is Tabloid itself, from the same company, sold without the brand name, and usually for less. For now Tabloid is the only choice; ask the pharmacy for its cash price, or your plan what it charges.
Regular genericNot sold
We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, ask the pharmacy for Tabloid’s cash price, or your plan what it charges.
What it’s used for
What the FDA label says
a) Acute Nonlymphocytic Leukemias
TABLOID brand Thioguanine is indicated for remission induction and remission consolidation treatment of acute nonlymphocytic leukemias. However, it is not recommended for use during maintenance therapy or similar long-term continuous treatments due to the high risk of liver toxicity (see WARNINGS and ADVERSE REACTIONS).
The response to this agent depends upon the age of the patient (younger patients faring better than older) and whether thioguanine is used in previously treated or previously untreated patients. Reliance upon thioguanine alone is seldom justified for initial remission induction of acute nonlymphocytic leukemias because combination chemotherapy including thioguanine results in more frequent remission induction and longer duration of remission than thioguanine alone.
b) Other Neoplasms
TABLOID brand Thioguanine is not effective in chronic lymphocytic leukemia, Hodgkin’s lymphoma, multiple myeloma, or solid tumors. Although thioguanine is one of several agents with activity in the treatment of the chronic phase of chronic myelogenous leukemia, more objective responses are observed with MYLERAN® (busulfan), and therefore busulfan is usually regarded as the preferred drug.
Source: the FDA label for Tabloid (Waylis Therapeutics LLC), January 8, 2025. Full label on DailyMed
Good to know
- We didn’t find a savings card from Tabloid’s maker.
- Don’t stop or change a medicine without talking to your pharmacist or prescriber.
Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/tabloid/